Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study (NCT06651580)

🧪 Interventions in This Study

• Biospecimen Collection (PROCEDURE)
• Quality-of-Life Assessment (OTHER)
• Questionnaire Administration (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (26 Sites)

Showing the first 25 of 26 sites.

• Children's Hospital Los Angeles — Los Angeles, California
• Cedars Sinai Medical Center — Los Angeles, California
• UCSF Benioff Children's Hospital Oakland — Oakland, California
• Stanford Cancer Institute Palo Alto — Palo Alto, California
• University of Colorado — Denver, Colorado
• Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
• Riley Hospital for Children — Indianapolis, Indiana
• University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa
• Ochsner Medical Center Jefferson — New Orleans, Louisiana
• Johns Hopkins University/Sidney Kimmel Cancer Center — Baltimore, Maryland
• Boston Children's Hospital — Boston, Massachusetts
• University of Minnesota/Masonic Children's Hospital — Minneapolis, Minnesota
• Washington University School of Medicine — St Louis, Missouri
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
• Nationwide Children's Hospital — Columbus, Ohio
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
• Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania
• University of Texas Southwestern/Children's Medical Center — Dallas, Texas
• M D Anderson Cancer Center — Houston, Texas
• Texas Children's Hospital — Houston, Texas
• Children's Hospital of San Antonio — San Antonio, Texas
• Children's Hospital of Wisconsin — Milwaukee, Wisconsin
• Sydney Children's Hospital — Randwick, New South Wales
• Hospital for Sick Children — Toronto, Ontario
• The Montreal Children's Hospital of the MUHC — Montreal, Quebec

📞 Contact the Study Coordinator

Phone: (713) 563-4271

Email: yyuan@mdanderson.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chronic Pancreatitis

• A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis — Los Angeles, California
• A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis — Columbus, Ohio
• Pancreatic Quantitative Sensory Testing (P-QST) — Cincinnati, Ohio
• Ivacaftor Impact in an Adolescent Without a Cystic Fibrosis-Associated CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Mutation for Chronic Pancreatitis: Single-Patient Study Tracking Flare Frequency and Health Data Compared to Historical Records. — Seattle, Washington
• VR Pilot for Pancreatitis — Los Angeles, California
• Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis — Redwood City, California

Explore by condition: All Chronic Pancreatitis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.